vs

Side-by-side financial comparison of Lucky Strike Entertainment Corp (LUCK) and Orthofix Medical Inc. (OFIX). Click either name above to swap in a different company.

Lucky Strike Entertainment Corp is the larger business by last-quarter revenue ($306.9M vs $219.9M, roughly 1.4× Orthofix Medical Inc.). Orthofix Medical Inc. runs the higher net margin — -1.0% vs -4.1%, a 3.1% gap on every dollar of revenue. On growth, Lucky Strike Entertainment Corp posted the faster year-over-year revenue change (2.3% vs 2.0%). Orthofix Medical Inc. produced more free cash flow last quarter ($16.8M vs $15.2M). Over the past eight quarters, Orthofix Medical Inc.'s revenue compounded faster (8.0% CAGR vs 0.2%).

Lucky Strike Entertainment Corporation is an American bowling center, family entertainment center and waterpark operator. It is the largest ten-pin bowling center operator in the world with over 360 centers throughout the United States, Canada and Mexico. The centers have an average of 40 lanes compared to the U.S. bowling center average of 21 lanes.

Orthofix Medical Inc. is a global medical device firm specializing in orthopedic care. It develops, manufactures and sells spinal implants, trauma care products, bone growth stimulation therapies and regenerative medicine offerings, serving orthopedic surgeons and healthcare providers across North America, Europe and Asia Pacific.

LUCK vs OFIX — Head-to-Head

Bigger by revenue
LUCK
LUCK
1.4× larger
LUCK
$306.9M
$219.9M
OFIX
Growing faster (revenue YoY)
LUCK
LUCK
+0.3% gap
LUCK
2.3%
2.0%
OFIX
Higher net margin
OFIX
OFIX
3.1% more per $
OFIX
-1.0%
-4.1%
LUCK
More free cash flow
OFIX
OFIX
$1.7M more FCF
OFIX
$16.8M
$15.2M
LUCK
Faster 2-yr revenue CAGR
OFIX
OFIX
Annualised
OFIX
8.0%
0.2%
LUCK

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
LUCK
LUCK
OFIX
OFIX
Revenue
$306.9M
$219.9M
Net Profit
$-12.7M
$-2.2M
Gross Margin
71.1%
Operating Margin
10.9%
0.2%
Net Margin
-4.1%
-1.0%
Revenue YoY
2.3%
2.0%
Net Profit YoY
-144.7%
92.4%
EPS (diluted)
$-0.11
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUCK
LUCK
OFIX
OFIX
Q4 25
$306.9M
$219.9M
Q3 25
$292.3M
$205.6M
Q2 25
$301.2M
$203.1M
Q1 25
$339.9M
$193.6M
Q4 24
$300.1M
$215.7M
Q3 24
$260.2M
$196.6M
Q2 24
$198.6M
Q1 24
$337.7M
$188.6M
Net Profit
LUCK
LUCK
OFIX
OFIX
Q4 25
$-12.7M
$-2.2M
Q3 25
$-13.8M
$-22.8M
Q2 25
$-74.7M
$-14.1M
Q1 25
$13.3M
$-53.1M
Q4 24
$28.3M
$-29.1M
Q3 24
$23.1M
$-27.4M
Q2 24
$-33.4M
Q1 24
$23.8M
$-36.0M
Gross Margin
LUCK
LUCK
OFIX
OFIX
Q4 25
71.1%
Q3 25
72.2%
Q2 25
68.7%
Q1 25
62.8%
Q4 24
69.0%
Q3 24
68.7%
Q2 24
67.8%
Q1 24
33.1%
67.5%
Operating Margin
LUCK
LUCK
OFIX
OFIX
Q4 25
10.9%
0.2%
Q3 25
9.7%
-8.3%
Q2 25
5.0%
-7.9%
Q1 25
18.3%
-25.2%
Q4 24
15.6%
-5.3%
Q3 24
5.0%
-9.6%
Q2 24
-12.5%
Q1 24
21.0%
-15.6%
Net Margin
LUCK
LUCK
OFIX
OFIX
Q4 25
-4.1%
-1.0%
Q3 25
-4.7%
-11.1%
Q2 25
-24.8%
-6.9%
Q1 25
3.9%
-27.4%
Q4 24
9.4%
-13.5%
Q3 24
8.9%
-13.9%
Q2 24
-16.8%
Q1 24
7.1%
-19.1%
EPS (diluted)
LUCK
LUCK
OFIX
OFIX
Q4 25
$-0.11
$-0.05
Q3 25
$-0.12
$-0.57
Q2 25
$-0.49
$-0.36
Q1 25
$0.07
$-1.35
Q4 24
$0.16
$-0.76
Q3 24
$0.13
$-0.71
Q2 24
$-0.88
Q1 24
$0.13
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUCK
LUCK
OFIX
OFIX
Cash + ST InvestmentsLiquidity on hand
$82.0M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$-363.8M
$450.0M
Total Assets
$3.3B
$850.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUCK
LUCK
OFIX
OFIX
Q4 25
$82.0M
Q3 25
$62.9M
Q2 25
$65.6M
Q1 25
$58.0M
Q4 24
$83.2M
Q3 24
$30.1M
Q2 24
$26.4M
Q1 24
$27.0M
Total Debt
LUCK
LUCK
OFIX
OFIX
Q4 25
$1.8B
Q3 25
$1.7B
$157.2M
Q2 25
$1.3B
$157.0M
Q1 25
$1.3B
$156.9M
Q4 24
$1.3B
$157.0M
Q3 24
$1.1B
$118.5M
Q2 24
$118.0M
Q1 24
$1.1B
$118.2M
Stockholders' Equity
LUCK
LUCK
OFIX
OFIX
Q4 25
$-363.8M
$450.0M
Q3 25
$-326.3M
$442.5M
Q2 25
$-298.7M
$458.3M
Q1 25
$-213.7M
$458.3M
Q4 24
$-179.7M
$503.1M
Q3 24
$-164.3M
$525.9M
Q2 24
$546.0M
Q1 24
$-76.0M
$570.3M
Total Assets
LUCK
LUCK
OFIX
OFIX
Q4 25
$3.3B
$850.6M
Q3 25
$3.2B
$832.6M
Q2 25
$3.2B
$837.2M
Q1 25
$3.2B
$823.1M
Q4 24
$3.2B
$893.3M
Q3 24
$3.1B
$867.9M
Q2 24
$882.0M
Q1 24
$3.2B
$906.0M
Debt / Equity
LUCK
LUCK
OFIX
OFIX
Q4 25
Q3 25
0.36×
Q2 25
0.34×
Q1 25
0.34×
Q4 24
0.31×
Q3 24
0.23×
Q2 24
0.22×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUCK
LUCK
OFIX
OFIX
Operating Cash FlowLast quarter
$48.1M
$27.7M
Free Cash FlowOCF − Capex
$15.2M
$16.8M
FCF MarginFCF / Revenue
4.9%
7.6%
Capex IntensityCapex / Revenue
10.7%
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$42.9M
$-1.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUCK
LUCK
OFIX
OFIX
Q4 25
$48.1M
$27.7M
Q3 25
$-6.4M
$12.4M
Q2 25
$22.5M
$11.6M
Q1 25
$86.6M
$-18.4M
Q4 24
$38.7M
$23.7M
Q3 24
$29.4M
$11.7M
Q2 24
$9.0M
Q1 24
$76.9M
$-18.6M
Free Cash Flow
LUCK
LUCK
OFIX
OFIX
Q4 25
$15.2M
$16.8M
Q3 25
$-32.3M
$2.5M
Q2 25
$-1.1M
$4.5M
Q1 25
$61.1M
$-25.1M
Q4 24
$-11.7M
$15.2M
Q3 24
$-12.2M
$6.3M
Q2 24
$-360.0K
Q1 24
$43.4M
$-29.1M
FCF Margin
LUCK
LUCK
OFIX
OFIX
Q4 25
4.9%
7.6%
Q3 25
-11.1%
1.2%
Q2 25
-0.4%
2.2%
Q1 25
18.0%
-13.0%
Q4 24
-3.9%
7.0%
Q3 24
-4.7%
3.2%
Q2 24
-0.2%
Q1 24
12.9%
-15.4%
Capex Intensity
LUCK
LUCK
OFIX
OFIX
Q4 25
10.7%
4.9%
Q3 25
8.9%
4.8%
Q2 25
7.8%
3.5%
Q1 25
7.5%
3.5%
Q4 24
16.8%
4.0%
Q3 24
16.0%
2.7%
Q2 24
4.7%
Q1 24
9.9%
5.6%
Cash Conversion
LUCK
LUCK
OFIX
OFIX
Q4 25
Q3 25
Q2 25
Q1 25
6.52×
Q4 24
1.37×
Q3 24
1.27×
Q2 24
Q1 24
3.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LUCK
LUCK

Bowling$142.9M47%
Food And Beverage Revenue Stream$112.4M37%
Amusement And Other$51.6M17%

OFIX
OFIX

Spinal Implants Biologics And Enabling Technologies$113.6M52%
Bone Growth Therapies$68.3M31%
Other$22.7M10%
IT$5.9M3%
GB$3.5M2%
FR$3.5M2%
DE$2.3M1%

Related Comparisons